MAPK8 and neoplasm: In addition, the anti-tumor properties of 4.1N were assessed in vitro and in vivo. Specifically, we identified that 4.1N interacts with PP1 and participates in the regulation of JNK-c-Jun signaling via the enhancement of the dephosphorylation of PP1.